Status | Study |
Withdrawn |
Study Name: Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% Condition: Optic Neuropathy, Ischemic Anterior Ische Date: 2012-05-25 Interventions: Drug: Timolol maleate Timolol 0.5% 1 drop twice daily to the effected eye for 4 weeks. |
Completed |
Study Name: NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement Condition: Ischemic Optic Neuropathy/Optic Nerve Stroke Date: 2011-08-05 Interventions: Drug: NT-501 CNTF Implant Single implantation of CNTF-secreting NT-501 device into one eye |
Completed |
Study Name: Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo Condition: Acute Nonarteritic Anterior Ischemic Optic Neuropathy Date: 2011-03-08 Interventions: Drug: Avastin and Triamcinolone |
Completed |
Study Name: Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Condition: Anterior Ischemic Optic Neuropathy Ischem Date: 2010-11-05 Interventions: Other: No intervention given in this observational study No intervention given in this observational stu |
Completed |
Study Name: A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors Condition: Nonarteritic Anterior Ischemic Optic Neuropathy Date: 2010-05-10 Interventions: Drug: PDE5 Inhibitors Observational study of participants who have been prescribed phosphodiesterase typ |
Completed |
Study Name: Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients Condition: Optic Atrophy Non-arteritic Anterior Ischemic Optic Neuropathy Date: 2010-02-04 Interventions: Drug: QPI-1007 at various doses Single Intravitreal Injection |
Recruiting |
Study Name: PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Condition: Anterior Ischemic Optic Neuropathy Date: 2009-03-23 Interventions: Drug: Diagnostic procedures The patients will not receive any study drug in this study. The patients wil |
Recruiting |
Study Name: Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy Condition: Non-arteritic Anterior Ischemic Optic Neuropathy Date: 2008-12-19 Interventions: Drug: Intra-vitreal injection of bevacizumab (1.25mg/0.05ml) Pars plana intra-vitreal injection of bevac |
Completed |
Study Name: A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION Condition: Optic Neuropathy, Ischemic Date: 2008-09-22 Interventions: Drug: No intervention No intervention occurs in this observational study. |
Completed |
Study Name: Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy Condition: Nonarteritic Anterior Ischemic Optic Neuropathy Date: 2007-11-19 Interventions: Drug: ranibizumab All patients (n=15) will be treated with open label 0.5mg ranibizumab given intravitre |